SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales figure stood at Rs. 54373.00 millions for the June 2023 quarter. The mentioned figure indicates a growth of about 49.76% as compared to Rs. 36306.00 millions during the year-ago period.Net Profit for the quarter ended June 2023 zoomed to 228.21% from Rs. 4995.00 millions to Rs. 16394.00  millions.Operating Profit saw a handsome growth to 24613.00 millions from 9829.00 millions in the quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 54373.00 36306.00 49.76 54373.00 36306.00 49.76 169625.00 144052.00 17.75
Other Income 2336.00 4034.00 -42.09 2336.00 4034.00 -42.09 5913.00 4820.00 22.68
PBIDT 24613.00 9829.00 150.41 24613.00 9829.00 150.41 48061.00 30761.00 56.24
Interest 45.00 98.00 -54.08 45.00 98.00 -54.08 169.00 380.00 -55.53
PBDT 24568.00 9731.00 152.47 24568.00 9731.00 152.47 47892.00 30381.00 57.64
Depreciation 2372.00 2215.00 7.09 2372.00 2215.00 7.09 9232.00 8143.00 13.37
PBT 22196.00 7516.00 195.32 22196.00 7516.00 195.32 38660.00 22238.00 73.85
TAX 5802.00 2521.00 130.15 5802.00 2521.00 130.15 12532.00 6006.00 108.66
Deferred Tax 415.00 1163.00 -64.32 415.00 1163.00 -64.32 3891.00 2080.00 87.07
PAT 16394.00 4995.00 228.21 16394.00 4995.00 228.21 26128.00 16232.00 60.97
Equity 833.00 832.00 0.12 833.00 832.00 0.12 833.00 832.00 0.12
PBIDTM(%) 45.27 27.07 67.21 45.27 27.07 67.21 28.33 21.35 32.69

Dr. Reddys Labs. Share Price

1335.10 33.80 (2.60%)
24-Jun-2026 12:39 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1875.95
Dr. Reddys Labs. 1335.10
Cipla 1441.00
Zydus Lifesciences 1099.70
Lupin 2385.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: